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Abstract 
Methods and Results for application of the quantile equating method to data from 
1H-NMR 
analysis of urine samples. For plasma LC-MS and 
1H-NMR data, PC1–PC2 loadings plots 
and lists with variables having lowest B1–B2 correlation of quantile values before equating. 
Typical examples of plasma 
1H-NMR spectra.   S2 
Materials and Methods (urine 
1H-NMR) 
 
Participant recruitment and characterization as well as urine sampling were performed 
according to the methods described previously.
1 In B1 and B2, urine 
1H-NMR spectra were 
obtained of nearly all participants of whom blood plasma samples were analyzed as well 
with LC–MS and 
1H-NMR (see main document). However, in B1 analysis of the urine 
sample of one participant was unsuccessful. In B2 the urine sample of one other participant 
was not analyzed. Without these two participants, the total number of participants of whom 
urine samples were analyzed in B1 and B2 together was equal to 180. The average ages of 
the twins of whom urine samples were analyzed in B1 and in B2, and of the siblings, were 
not different from those of the twins and siblings of whom blood plasma samples were 
analyzed with LC–MS and 
1H-NMR. Of four participants only two out of three replicate 
NMR  analyses  were  successful.  In  B2,  for  the  purpose  of  quality  control  of  the  NMR 
analyses QC samples were prepared prior to sample preparation by pooling equal amounts 
of urine sample from the study participants who were measured in that block. 
Before  NMR  spectroscopic  analysis,  1  mL  urine  samples  from  all  subjects  were 
lyophilized and reconstituted in 700  L deuterated sodium phosphate buffer (0.1 mmol/L, 
pH  7.4  made  up  with  D2O),  to  minimize  spectral  variance  arising  from  differences  in 
urinary pH. Sodium trimethylsilyl-[2,2,3,3,-2H4]-1-propionate (TMSP; 0.025 mmol/L) was 
added as an internal standard for chemical shift. 600  l of the samples was transferred to 5 
mm outer diameter NMR tubes. 
Then, the measurement order of the urine samples of the individual study participants was 
randomized.  In  B2,  after  this  randomization,  uniformly  distributed  pooled  QC  sample 
aliquots were inserted. Furthermore, in B2 following each of these QC sample aliquots, 
samples were inserted of in total eleven participants that had already been analyzed in B1. 
These samples thus underwent an additional freeze-thaw cycle between B1 and B2. 
NMR spectra were acquired in triplicate on a fully automated Bruker Avance 600 MHz 
spectrometer (Bruker Analytik GmbH, Karlsruhe, Germany) using a standard 1D 
1H NMR 
pulse sequence with water suppression (zgpr) and operating at an internal probe temperature 
of 300K. Typically 128 transients were acquired into 64·10
3 data points using a spectral 
width of 12 kHz; 45° pulses were used with an acquisition time of 2.7 s and a relaxation 
delay of 2 s. The signal of the residual water was removed by a presaturation technique in 
which the water peak was irradiated with a constant frequency during the relaxation delay. 
The spectra were processed using XWIN–NMR software (v.3.1, Bruker Analytik GmbH). 
The FIDs were multiplied by  an exponential weighing function corresponding to a line 
broadening of 0.3 Hz prior to Fourier transform. The acquired NMR spectra were manually 
phased, baseline-corrected and referenced to the TMSP resonance at 0.0 ppm. The urine 
NMR data were processed further in the way as described for the plasma NMR data in the 
main  document.  Where  applicable,  names  of  chemical  compounds  were  assigned  to 
chemical shifts (ppm values) on basis of an in-house reference database.   S3 
Results and Discussion (urine 
1H-NMR) 
 
After  application  of  the  ‘80%-rule’,  199  features  (variables)  were  kept  for  further 
analysis. 
Typical  examples  of 
1H-NMR  spectra  of  urine  samples  from  B1  and  from  B2  are 
presented in Figure S1. 
 
Figure S1. Typical 
1H-NMR spectra of urine from B1 (panel A) and B2 (panel B). Spectra 
in panel A, and in Figure S6A are from the same participant. Similarly, spectra in panel B, 
and in Figure S6B are from the same participant. The signal at 0 ppm originates from the 
reference standard TMSP.   S4 
The consecutive replicate analyses of each sample displayed a decrease of the signal at 
4.06 ppm, particularly in B1. Presumably this is a result of progressive exchange over time 
of methylene protons with deuterium in the creatinine molecule.
2,3 Because this exchange 
occurred  exclusively  at  the  methylene  group  of  the  creatinine  molecule  its  effect  was 
observed  only  in  the  signal  at  4.06  ppm  and  not  in  the  other  creatinine  signals  in  the 
spectrum. The replicate measurements of the eleven prepared samples that were measured 
in both B1 and B2 displayed a notable decrease of the signal at this position in B1 but not in 
B2, presumably because in B2 the exchange had attained a chemical balance situation. After 
exclusion  of  the  variable  corresponding  to  this  signal  from  the  data,  specifically  the 
variables corresponding to the signals at 3.28 ppm and at 3.05 ppm caused separation of the 
measurements of both years along the first two PCs in PCA (not shown). Presumably this 
was due to the signals at these chemical shift values to exceed plateau values in the peak 
detection software in a number of measurements. Prior to median normalization of the data, 
these two variables were excluded for further analysis as well. 
Figure S2 shows the results of PCA on the urine 
1H-NMR data from B1 and B2 prior to 
between-block effect correction.   S5 
 
Figure S2. PCA scores (panel A) and loadings (panel B) on PC1 and PC2 for the combined 
(concatenated)  B1–B2  urine  NMR  datasets  before  correction  for  between-block  effects. 
Scores based on measurements in B1 and in B2 of individual samples that were measured in 
both years, are connected by lines in panel A. The percentages of variance explained by the 
respective PCs are given between brackets in the axes labels. Denotation of markers in 
panel A: ●, B1 individual study  sample; ○,  B2 individual study sample; ￿,  B2  QC 
sample aliquot measured in B2; ￿, B1 individual study sample measured again in B2. In 
panel B, loadings are labeled by chemical shift (ppm value).   S6 
The scores plot (Figure S2A) suggests that there is a multiplicative difference between the 
B1 and the B2 data, although this between-block effect is not as profound as was seen in 
case of the plasma LC–MS and NMR data (main document Figure 2 panel A and panel C, 
respectively).  Compared  to  these  other  types  of  data,  in  the  urine  NMR  data  the 
within-block variance is relatively larger with respect to the between-block variance. This is  
probably due to the large biological interindividual variation that is typically observed in 
urine 
1H-NMR spectra. 
The correlation between the B1 and the B2 quantiles was on average 0.92 (SD 0.08). The 
variables in the urine NMR data that displayed the lowest Pearson correlations between the 
B1 and the B2 quantiles are listed in Table S1. 
 
 
Table S1. Urine 
1H-NMR features with lowest B1–B2 correlation of quantile values before 
equating 
Chemical shift (ppm)  Pearson’s R 
1.3343 
1.3460 
1.9172 
4.5407 
2.1910 
2.8306 
8.3517 
1.2275 
7.2996 
3.7926 
0.4698 
0.5386 
0.6211 
0.6851 
0.6883 
0.7223 
0.7231 
0.7302 
0.7419 
0.7522 
 
 
The values of the parameters that evaluate similarity of datasets in the multivariate space 
before and after equating are given for the urine NMR data in Table S2.   S7 
Table S2. Similarity of B1 and B2 urine NMR datasets in the PC space before (panel A) 
and after (panel B) quantile equating 
 
A 
  1 PC  2 PCs  3 PCs  4 PCs  5 PCs  6 PCs  7 PCs  8 PCs  9 PCs  10 PCs  11 PCs 
P 
C 
R 
0.9421 
0.9979 
0.9776 
0.7716 
0.9538 
0.0566 
0.7009 
0.9177 
0.2497 
0.7054 
0.8713 
0 
0.6991 
0.7964 
0 
0.7083 
0.7324 
0 
0.6896 
0.6216 
0 
0.6773 
0.5367 
0 
0.6832 
0.5129 
0 
0.6794 
0.4791 
0 
0.6832 
0.4302 
0 
 
B 
  1 PC  2 PCs  3 PCs  4 PCs  5 PCs  6 PCs  7 PCs  8 PCs  9 PCs  10 PCs  11 PCs 
P 
C 
R 
0.9562 
0.9947 
0.9997 
0.8943 
0.9832 
0.9969 
0.8821 
0.9541 
0.9937 
0.8836 
0.8945 
0.9948 
0.876 
0.868 
0.9956 
0.8434 
0.8158 
0.993 
0.8686 
0.6944 
0.9931 
0.8759 
0.5836 
0.9936 
0.8758 
0.519 
0.9941 
0.874 
0.4828 
0.9944 
0.8713 
0.4312 
0.9948 
 
Similarity  of  B1  and  B2  urine 
1H-NMR  datasets  before  (panel A)  and  after  (panel B) 
quantile equating. P, B1–B2 similarity of PCA loadings patterns; C, B1–B2 similarity of 
variance-covariance matrices; R, B1–B2 similarity of dataset centroid locations. 
 
The values in Table S2A for the P and C parameters suggest that the  PCA loadings 
patterns and variance-covariance matrices are rather similar for the B1 and B2 data even 
without equating. However, the R parameter values when computed for more than one PC 
suggest that the centroid locations of both datasets are different prior to equating. This can 
be seen in Figure S2A as well, where the scores of the B1 and of the B2 data are separated 
mainly along PC2. 
Figure S3 shows the PCA scores and loadings plots of the B1 and B2 data together after 
equating.   S8 
 
Figure S3. PCA scores (panel A) and loadings (panel B) on PC1 and PC2 for the combined 
(concatenated)  B1–B2  urine  NMR  datasets  after  quantile  equating.  The  percentages  of 
variance explained by the respective PCs are given between brackets in the axes labels. 
Denotation of markers in panel A: ●, B1 individual study sample; ○, B2 individual study 
sample; ￿, B2 QC sample aliquot measured in B2. In panel B, loadings are labeled by 
chemical shift (ppm value).   S9 
As expected on basis of the relatively small between-block effect as suggested by the 
PCA scores plot before equating (Figure S2A), the scores and loadings plots before (Figure 
S2) and after (Figure S3) equating are rather similar as well. Similarly as in case of the 
plasma LC–MS and NMR data (see main document Figure 2 panels C and D), the scores 
based on the measurements of individual samples in B1 and B2 are dispersed among each 
other after equating (Figure S3A). Also, the scores based on measurements of pooled QC 
sample in B2 are again located in the center of the PCA scores plot. After equating, the 
patterns of PCA scores of replicate measurements with respect to each other within each 
block were similar to those before equating (not shown). 
The values after equating of the parameters that evaluate similarity of datasets in the 
multivariate space are given in Table S2B. The values in Table S2B for the R parameter 
suggest that the centroid locations of the B1 and B2 urine NMR data with inclusion of more 
than 1 PC have become much more similar. This is as expected on basis of the nature of the 
quantile equating method, and can also be observed in Figure S3A. The values for the P and 
for the C parameters have increased slightly as well.   S10 
PCA loadings plots for plasma LC–MS and for plasma NMR datasets 
 
Plasma LC–MS 
 
PC1–PC2 loadings plots for the combined (concatenated) B1  and B2 plasma  LC–MS 
datasets before and after equating are given in Figure S4. 
 
Figure S4. PC1–PC2 loadings plots for the combined (concatenated) B1–B2 plasma LC–
MS data before (panel A) and after (panel B) quantile equating. The percentages of variance 
explained by the respective PCs are given between brackets in the axes labels. See main 
document Figure 2 panels A and B for the corresponding scores plots.   S11 
Plasma NMR 
 
PC1–PC2  loadings  plots  for  the  combined  (concatenated)  B1  and  B2  plasma  NMR 
datasets before and after equating are given in Figure S5. 
 
Figure S5. PC1–PC2 loadings plots for the combined (concatenated) B1–B2 plasma NMR 
datasets before (panel A) and after (panel B) quantile equating. The percentages of variance 
explained by the respective PCs are given between brackets in the axes labels. Loadings are 
labeled by chemical shift (ppm value). See main document Figure 2 panels C and D for the 
corresponding scores plots.   S12 
Examples of plasma NMR spectra 
 
Typical examples of NMR spectra of plasma samples from B1 and B2 are presented in 
Figure S6. 
 
Figure  S6.  Typical  1H-NMR  spectra  of  plasma  from  B1  (panel  A)  and  B2  (panel  B). 
Spectra in panel A, and in Figure S1A are from the same participant. Similarly, spectra in 
panel B, and in Figure S1B are from the same participant. Differences between 4.8 and 5.0 
ppm  in  panel  A  and  B  are  due  to  the  differences  in  the  effectiveness  of  the  water 
suppression during acquisition of the spectra.   S13 
Variables  in  plasma  LC–MS  and  NMR  data  with  lowest  B1–B2 
correlation of quantile values 
 
Plasma LC–MS 
 
The variables in the plasma LC–MS and NMR data having the lowest B1–B2 correlation 
of quantile values before quantile equating are listed in Table S3. 
 
 
Table  S3.  Plasma  lipids  (panel A)  and  NMR  features  (panel B)  with  lowest  B1–B2 
correlation of quantile values before correction for between–block effects 
A 
Lipid  Pearson’s R 
C36:5_PC 
C48:2_TG 
C50:4_TG 
C54:2_TG 
C48:3_TG 
C48:1_TG 
C50:2_TG 
C50:3_TG 
C50:1_TG 
C46:0_TG 
0.8254 
0.8946 
0.9037 
0.9106 
0.9209 
0.9220 
0.9283 
0.9372 
0.9501 
0.9521 
 
 
B 
Chemical shift (ppm)  Pearson’s R 
1.9238 
2.0825 
3.8660 
0.9753 
3.7258 
3.6189 
1.0087 
3.9011 
3.5504 
3.6256 
0.5996 
0.6546 
0.7045 
0.7095 
0.7409 
0.7529 
0.7726 
0.7737 
0.7955 
0.7962 
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